LobE-Specific lymph node diSsectiON for clinical early-stage non-small cell lung cancer: protocol for a randomised controlled trial (the LESSON trial)
Introduction Lung cancer was the most common malignancy and the leading cause of cancer-related death in China or worldwide, and surgery is still the preferred treatment for early-stage non-small cell lung cancer (NSCLC). The pattern of lymph node metastasis was found potentially lobe specific, and...
Main Authors: | Xiaojun Tang, Kai Xu, Weijia Huang, Han-Yu Deng, Zhi-Zhen Ren, Yi-Feng Wang, Da-Xing Zhu, Qinghua Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-08-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/8/e056043.full |
Similar Items
-
Lobe-specific lymph node dissection in early-stage non-small-cell lung cancer: An overview
by: Lei Peng, et al.
Published: (2023-02-01) -
Comparison of the Outcomes between Systematic Lymph Node Dissection and Lobe-Specific Lymph Node Dissection for Stage I Non-small Cell Lung Cancer
by: Ching-Chun Huang, et al.
Published: (2023-04-01) -
10-Year axillary recurrence in the RACS SNAC1 randomised trial of sentinel lymph node-based management versus routine axillary lymph node dissection
by: Ian Campbell, et al.
Published: (2023-08-01) -
Protocol for a Pilot Study of the NODE Trial, a Prospective Multicentre Randomised Trial of Extended Pelvic Lymph Node Dissection for High-Risk Prostate Cancer
by: George McClintock, et al.
Published: (2021-11-01) -
Clinical Benefits of Lobe-Specific Lymph Node Dissection in Surgery for NSCLC: A Systematic Review and Meta-Analysis
by: Wongi Woo, MD, et al.
Published: (2023-05-01)